← Leaderboards
Patrick M Sullivan
Duke University
$1,784,838
Attributed
$1,784,838
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $254.2K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,784,838 · 4
By mechanism
R01$859,901 · 1
P50$627,706 · 1
P41$297,231 · 2
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Guoping Feng$46,416,541
- Ashutosh Chilkoti$32,367,884
- Henry Yin$16,962,206
- Chay Titus Kuo$8,416,971
- Michael Peter Vitek$14,740,646
Others in their field
Top investigators on “Apolipoprotein E”
- Randall J Bateman · Washington University$84,991,900
- Eric M Reiman · Banner Health$54,703,271
- Jose A Luchsinger · Columbia University Health Sciences$53,467,373
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Paul S. Aisen · Cognition Therapeutics, Inc.$44,864,980
Research focus
Apolipoprotein ECholesterolProtein IsoformsAlzheimer&AposGenetic StrainHuman TissueNuclear Magnetic Resonance SpectroscopyDietary LipidGene Environment InteractionDisease /Disorder Proneness /RiskGenetic ModelsAmyloid ProteinsGenetic SusceptibilityGenetic TranscriptionLaboratory MouseBrain MetabolismModel Design /DevelopmentGene InteractionAlzheimer'S DiseaseBiomedical ResourceDisease /Disorder ModelDisease /Disorder OnsetGenetically Modified AnimalsNorthern Blottings
Grant awards (15)
A HUMAN APOE MOUSE MODEL OF ALZHEIMER?S DISEASE$5,460
P41 · FY2010 · RR · contact PI
APOE4 and Loss of Synaptic Integrity$200,536
R01 · FY2009 · AG · contact PI
APOE4 and Loss of Synaptic Integrity$200,536
R01 · FY2008 · AG · contact PI
APOE4 and Loss of Synaptic Integrity$204,629
R01 · FY2007 · AG · contact PI
APOE4 and Loss of Synaptic Integrity$254,200
R01 · FY2006 · AG · contact PI
IN VIVO MRM OF TRANSGEN ANIMAL MODEL OF CEREBRAL AMYLOID ANGIOPATHY: HEMORRHAGE$0
P41 · FY2002 · RR
IN VIVO MRM OF TRANSGEN ANIMAL MODEL OF CEREBRAL AMYLOID ANGIOPATHY: HEMORRHAGE$0
P41 · FY2002 · RR
CHOLESTEROL EFFECTS ON HUMAN ApoE AND APP INTERACTIONS$0
P50 · FY2002 · AG
CHOLESTEROL EFFECTS ON HUMAN ApoE AND APP INTERACTIONS$0
P50 · FY2002 · AG
CHOLESTEROL EFFECTS ON HUMAN ApoE AND APP INTERACTIONS$313,853
P50 · FY2001 · AG
IN VIVO MRM OF TRANSGEN ANIMAL MODEL OF CEREBRAL AMYLOID ANGIOPATHY: HEMORRHAGE$288,015
P41 · FY2001 · RR
CHOLESTEROL EFFECTS ON HUMAN ApoE AND APP INTERACTIONS$0
P50 · FY2001 · AG
IN VIVO MRM OF TRANSGEN ANIMAL MODEL OF CEREBRAL AMYLOID ANGIOPATHY: HEMORRHAGE$0
P41 · FY2001 · RR
CHOLESTEROL EFFECTS ON HUMAN ApoE AND APP INTERACTIONS$313,853
P50 · FY2000 · AG
IN VIVO MRM OF TRANSGEN ANIMAL MODEL OF CEREBRAL AMYLOID ANGIOPATHY: HEMORRHAGE$3,756
P41 · FY2000 · RR